| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.09 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.09 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |